Deferasirox

Product NDC: 67877-549
11-digit product format: 678770549
Labeler code: 67877
Product ID: 67877-549_1a5b6d3f-ad5c-43f7-bed3-4b51ae26f872
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Deferasirox
Dosage form: TABLET, FOR SUSPENSION
Route: ORAL
Labeler: Ascend Laboratories, LLC
Application: ANDA210519
Marketing category: ANDA
Marketing start: 2019-11-22
Substance: DEFERASIROX
Active strength: 125 mg/1
Pharmacologic classes: Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A210519-001	DEFERASIROX	DEFERASIROX	125MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20
A210519-002	DEFERASIROX	DEFERASIROX	250MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20
A210519-003	DEFERASIROX	DEFERASIROX	500MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A210519-001	AB
A210519-002	AB
A210519-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 114 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A210519-001	DEFERASIROX	125MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210519-002	DEFERASIROX	250MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210519-003	DEFERASIROX	500MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210519-001	DEFERASIROX	125MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210519-002	DEFERASIROX	250MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210519-003	DEFERASIROX	500MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A210519-001	DEFERASIROX	125MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210519-002	DEFERASIROX	250MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210519-003	DEFERASIROX	500MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210519-001	DEFERASIROX	125MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210519-002	DEFERASIROX	250MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210519-003	DEFERASIROX	500MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210519-001	DEFERASIROX	125MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210519-002	DEFERASIROX	250MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210519-003	DEFERASIROX	500MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210519-001	DEFERASIROX	125MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210519-002	DEFERASIROX	250MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210519-003	DEFERASIROX	500MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210519-001	DEFERASIROX	125MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210519-002	DEFERASIROX	250MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210519-003	DEFERASIROX	500MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210519-001	DEFERASIROX	125MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210519-002	DEFERASIROX	250MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210519-003	DEFERASIROX	500MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210519-001	DEFERASIROX	125MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210519-002	DEFERASIROX	250MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210519-003	DEFERASIROX	500MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A210519-001	DEFERASIROX	125MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A210519-002	DEFERASIROX	250MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A210519-003	DEFERASIROX	500MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210519-001	DEFERASIROX	125MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210519-002	DEFERASIROX	250MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210519-003	DEFERASIROX	500MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210519-001	DEFERASIROX	125MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210519-002	DEFERASIROX	250MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210519-003	DEFERASIROX	500MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210519-001	DEFERASIROX	125MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210519-002	DEFERASIROX	250MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210519-003	DEFERASIROX	500MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A210519-001	DEFERASIROX	125MG	TABLET, FOR SUSPENSION / ORAL	AB	2019-11-20	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 114 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A210519-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210519-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210519-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210519-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210519-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210519-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A210519-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210519-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210519-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210519-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210519-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210519-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210519-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210519-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210519-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210519-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210519-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210519-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210519-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210519-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210519-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210519-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210519-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210519-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210519-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210519-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210519-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A210519-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A210519-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A210519-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210519-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210519-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210519-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210519-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210519-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210519-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210519-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210519-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210519-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A210519-001	AB	1	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: Deferasirox
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DEFERASIROX	125 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
V8G4MOF2V9	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
597768	Internal RxNorm lookup
597770	Internal RxNorm lookup
597772	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
da3295fc-5210-46a3-a5cc-7b9ec9265eca	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
1e1ec29c-8ce7-9963-3c87-cf7d9cd3b139	Product name	5	20250624
726062af-1135-4707-a1d7-57256991bbf9	Product name	2	20250226
0feb0248-301d-406d-9b41-7d80ddbec8a8	Product name	4	20201216
19c71a3d-ed9c-166b-a7e5-38c250c35631	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
67877-549-30	Deferasirox	30 in 1 BOTTLE	TABLET, FOR SUSPENSION	30		17

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
67877-549-30	EA - Each	67877-549	637ce813-83f2-4a73-bdaf-0c10fb2d8800	1	2019-12-10

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
67877-549	DEFERASIROX TABLET, FOR SUSPENSION [ASCEND LABORATORIES, LLC]	15	Current NDC, Legacy NDC, 1 package rows	20220528_da3295fc-5210-46a3-a5cc-7b9ec9265eca.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Deferasirox	DEFERASIROX	Ascend Laboratories, LLC	da3295fc-5210-46a3-a5cc-7b9ec9265eca	2025-07-11	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210519 application number: ANDA210519 ndc (product): 67877-549

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
V8G4MOF2V9	DEFERASIROX	201530-41-8	DEFERASIROX

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
597768	deferasirox 125 MG Tablet for Oral Suspension	PSN	da3295fc-5210-46a3-a5cc-7b9ec9265eca	17
597770	deferasirox 250 MG Tablet for Oral Suspension	PSN	da3295fc-5210-46a3-a5cc-7b9ec9265eca	17
597772	deferasirox 500 MG Tablet for Oral Suspension	PSN	da3295fc-5210-46a3-a5cc-7b9ec9265eca	17
597768	deferasirox 125 MG Tablet for Oral Suspension	SCD	da3295fc-5210-46a3-a5cc-7b9ec9265eca	17
597770	deferasirox 250 MG Tablet for Oral Suspension	SCD	da3295fc-5210-46a3-a5cc-7b9ec9265eca	17
597772	deferasirox 500 MG Tablet for Oral Suspension	SCD	da3295fc-5210-46a3-a5cc-7b9ec9265eca	17

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
67877-549-30	67877054930	30 TABLET, FOR SUSPENSION in 1 BOTTLE (67877-549-30)	2019-11-22	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Deferasirox	Ascend Laboratories, LLC \| Alkem Laboratories Limited	2025-07-11	Human Prescription Drug Label	17